Repligen Corp (RGEN): Next-Year EPS Estimate 28.87%
As of 2026-06-04, Repligen Corp (RGEN) has a next-year EPS growth estimate of 28.87%.
On 2026-06-03, analyst consensus for RGEN's next-year EPS growth shifted from 29.05% to 28.87% — a negative change of 0.18 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 17.14%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 28.87%
- EPS growth this year
- 17.14%
- EPS next quarter (est)
- $0.45
- Last price
- $126.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 28.87% | 17.14% | $0.45 | $126.55 |
| 2026-06-03 | 28.87% | 17.14% | $0.45 | $121.73 |
| 2026-06-02 | 29.05% | 17.03% | $0.45 | $121.13 |
| 2026-06-01 | 29.34% | 17.03% | $0.45 | $123.10 |
| 2026-05-31 | 29.34% | 17.03% | $0.45 | $123.95 |
| 2026-05-28 | 29.34% | 17.03% | $0.45 | $122.73 |
| 2026-05-27 | 29.34% | 17.03% | $0.45 | $113.17 |
| 2026-05-26 | 29.34% | 17.03% | $0.45 | $115.19 |
| 2026-05-25 | 29.34% | 17.03% | $0.45 | $115.06 |
| 2026-05-24 | 29.34% | 17.03% | $0.45 | $115.06 |
| 2026-05-21 | 29.34% | 17.03% | $0.45 | $113.37 |
| 2026-05-20 | 29.34% | 17.03% | $0.45 | $111.74 |
| 2026-05-19 | 29.34% | 17.03% | $0.45 | $108.52 |
| 2026-05-18 | 29.34% | 17.03% | $0.45 | $104.20 |
| 2026-05-17 | 29.34% | 17.03% | $0.45 | $102.87 |
| 2026-05-14 | 29.43% | 17.07% | $0.45 | $103.38 |
| 2026-05-13 | 29.31% | 17.07% | $0.45 | $107.55 |
| 2026-05-12 | 29.31% | 17.07% | $0.45 | $113.60 |
| 2026-05-11 | 29.31% | 17.07% | $0.45 | $115.91 |
| 2026-05-10 | 29.31% | 17.07% | $0.45 | $123.46 |
| 2026-05-07 | 29.40% | 16.97% | $0.45 | $126.43 |
| 2026-05-06 | 29.55% | 16.91% | $0.45 | $125.76 |
| 2026-05-05 | 29.28% | 15.34% | $0.46 | $125.61 |
| 2026-05-04 | 29.65% | 15.07% | $0.38 | $118.21 |
| 2026-05-03 | 29.65% | 15.07% | $0.38 | $117.20 |
| 2026-04-30 | 29.65% | 15.07% | $0.38 | $118.31 |
| 2026-04-29 | 29.65% | 15.07% | $0.38 | $113.11 |
| 2026-04-28 | 29.65% | 15.07% | $0.38 | $117.43 |
| 2026-04-27 | 29.65% | 15.07% | $0.38 | $118.29 |
| 2026-04-26 | 29.65% | 15.07% | $0.38 | $117.60 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Repligen Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Repligen Corp (RGEN) has a next-year EPS growth estimate of 28.87%, based on analyst consensus.
When was the latest EPS estimate revision for RGEN?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 29.05% to 28.87%.
What sector and industry does Repligen Corp belong to?▾
Repligen Corp operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RGEN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Repligen Corp (RGEN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports